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Influence of relative NK–DC abundance on
placentation and its relation to epigenetic
programming in the offspring
N Freitag1,4, MV Zwier2,4, G Barrientos1, I Tirado-Gonza´lez1, ML Conrad1, M Rose1, SA Scherjon3, T Plo¨sch3,5 and SM Blois*,1,5
Normal placentation relies on an efficient maternal adaptation to pregnancy. Within the decidua, natural killer (NK) cells and
dendritic cells (DC) have a critical role in modulating angiogenesis and decidualization associated with pregnancy. However, the
contribution of these immune cells to the placentation process and subsequently fetal development remains largely elusive.
Using two different mouse models, we here show that optimal placentation and fetal development is sensitive to disturbances in
NK cell relative abundance at the fetal–maternal interface. Depletion of NK cells during early gestation compromises the
placentation process by causing alteration in placental function and structure. Embryos derived from NK-depleted dams suffer
from intrauterine growth restriction (IUGR), a phenomenon that continued to be evident in the offspring on post-natal day 4.
Further, we demonstrate that IUGR was accompanied by an overall reduction of global DNA methylation levels and epigenetic
changes in the methylation of specific hepatic gene promoters. Thus, temporary changes within the NK cell pool during early
gestation influence placental development and function, subsequently affecting hepatic gene methylation and fetal metabolism.
Cell Death and Disease (2014) 5, e1392; doi:10.1038/cddis.2014.353; published online 28 August 2014
Maternal adaptations to pregnancy are critical during mam-
malian development. Cumulative evidence suggests that
immune-competent cells in the developing decidua are
important for placental development and embryo survival.
For instance, the cross-talk between natural killer (NK) cells
and dendritic cells (DC) during early pregnancy has emerged
as a key regulator of angiogenesis and decidualization,1,2
both of which are critical events for normal placentation.
In this context, we have shown that NK cells prevent the
development of alloimmunity during normal pregnancy by
modulating the immune-regulatory functions of DC during
early gestation.2,3 Furthermore, unbalanced relative NK cell
abundance (i.e., upon in vivo NK cell depletion following fms-
like tyrosine kinase 3 ligand (FL)-mediated DC expansion)
upregulated the expression of anti-angiogenic growth factors,
suggesting that NK cells are required for early vascular
responses associated with pregnancy. Indeed, NK cells
regulate the remodeling of maternal spiral arteries, transform-
ing them from low capacity high resistance into high capacity
low resistance vessels.4 As for DC, these cells not only
influence maternal immune tolerance to fetal alloantigens,3
but also coordinate pregnancy-associated vascular adapta-
tions including vessel permeability and blood flow to the
implantation site via the CXCL12/CXCR4 pathway.1,5
The placenta is the key organ supporting the survival and
growth of the fetus during gestation. It constitutes an interface
between the maternal and fetal circulations, allowing nutrient
uptake, waste elimination and metabolic/gas exchange.6
In mice, placental development begins early in the blastocyst
(embryonic day E3.5) and continues to show dramatic
changes throughout gestation. The mouse placenta consists
of three layers: the labyrinth (comprising highly branched
villi that maximize nutrient transport), the junction zone
(containing trophoblast giant cells and spongiotrophoblast
cells that invade the decidua and maternal vessels) and the
maternal decidua (including immune and decidual cells and
the maternal vasculature).7 Inadequate differentiation of
these layers leads to detrimental changes in placental
architecture, which affect the supply of nutrients or oxygen
to the fetus. Faulty placental development has been
implicated in the pathophysiology of several human preg-
nancy disorders, including preeclampsia, intrauterine growth
restriction (IUGR) and preterm labor.7 In this context, it is likely
that the fetus adapts to the pathological situation by modifying
its energy metabolism in order to sustain development and
continue pregnancy.
Changes in fetal metabolism are thought to occur via
epigenetic modification of mitochondrial gene expression
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patterns, causing changes in mitochondrial number or
function.8,9 Indeed, animal models of IUGR have shown a
reduction in mitochondrial DNA (mtDNA) content, accompa-
nied by reduced expression of mtDNA encoded genes and
epigenetic changes in fetal growth factors (e.g., insulin-like
growth factor I (IgfI) and IgfII). In addition, many studies have
suggested a role for nuclear receptors in the observed fetal
metabolic adaptations toward adverse conditions in utero.
These include receptors and associated coactivators, such as
the peroxisome proliferator-activated receptor alpha (Ppara),
peroxisome proliferator-activated receptor gamma coactiva-
tor 1 alpha (Pgc1a), hepatocyte nuclear factor 4 alpha (Hnf4a)
and the glucocorticoid receptor (Nr3c1).8 During adaptation to
restricted fetal development, modifications to nuclear recep-
tors act to optimize growth and differentiation. In a process
called fetal programming, these modifications can persist
through adulthood possibly contributing to the observed
increase in late-onset disorders at an adult age.10,11
As the cross-talk between NK cells and DC influences both
decidualization and angiogenesis, in this work we analyzed
how in vivo manipulation of relative DC–NK cell abundance
within the decidua impacts the placentation process and
subsequently fetal development. We show that although
manipulation of the relative abundance of DC and NK cells in
early gestation does not seem to compromise fetal survival,
both placental function and structure are specifically altered
compared with control mice. Using a candidate gene
approach, we demonstrate that these structural changes in
the placenta are associated with epigenetic changes in the
methylation of specific hepatic gene promoters in pups
principally after NK cell depletion. The gene-specific changes
were further accompanied by an overall reduction of global
DNA methylation levels. Our data confirm that temporary
changes within the NK and/or the DC pool during early
gestation influence placental development and function,
subsequently affecting hepatic gene methylation and fetal
metabolism.
Results
Temporary aNK in utero affects fetal and post-natal body
weight. We recently established a mouse model in which
DC expansion (eDC) or NK cell ablation (aNK) during early
pregnancy provoked changes in the decidualization and
angiogenesis processes associated with implantation, but did
not affect fetal survival.2 In the eDC model, we treated
CD11c.DTR female mice, whose pregnancy outcome para-
meters are comparable with C57BL/6 dams,12 during early
pregnancy with Fms-related tyrosine kinase 3 ligand (FL) for
5 days ensuring a three-fold expansion of DC population
within the decidua.2 For aNK, an antibody-mediated deple-
tion strategy was chosen over a mouse strain with a genetical
NK cell deficiency, because we pursued temporal ablation of
NK cells during our experiment over a permanent NK cell
deficiency.2 Of note, the antibody-mediated strategy-specific-
depleted NK cells without altering other cell subsets (i.e.,
granulocytes; Supplementary Figure 1). In order to determine
whether temporary changes in NK cell or DC relative
abundance during early gestation could have an impact on
fetal growth, we characterized the offspring of aNK and eDC
mice from E13.5 through post-natal day (PN)-4, and
compared them with control mice (Figure 1a). In these
Figure 1 Effects of NK cell ablation and DC expansion on pregnancy progression and fetal development. (a) Experimental design: pregnant CD11c-DTR females were
injected i.p. with anti-asialo GM1 for NK ablation on E4.5 or with 10 mg FL for DC expansion from E0.5 to 7.5, as described in methods. Fetuses (E13.5 and 16.5) or pups (post-
natal day 4, PN4) were analyzed. (b) Pregnancy progression following NK cell depletion or DC expansion in female mice. Mean length of gestation (days) did not vary among
the different groups analyzed. (c) Gender distribution of offspring from aNK and eDC female mice. No differences were observed in the percentage of male and female pups
with respect to controls. (d–f) Left panels: morphometric characterization of fetal development in aNK and eDC female mice. The figure shows representative examples of
fetuses (E13.5 and E16.5) and pups (PN4) obtained from control, aNK and eDC dams. Scale bar¼ 0.5 cm. Analysis of fetal development following NK cell depletion or DC
expansion in female mice. Fetuses carried by aNK or eDC females on E13.5 and 16.5 showed no differences in Theiler stage of development with respect to control mice.
(d–f) Right panels: mean body weights resistered in the offspring following NK depletion or DC expansion during early pregnancy. Reduction of body weight was detected in
E13.5, E16.5 fetuses carried by aNK dams, which persists until PN4 with respect to weights rescorded in control and eDC mice. In all figures, data shown are mean±S.E.M.
derived from six to eight mice per group or 48–56 embryos/pups per group. Differences are denoted as *Po0.05 and **Po0.001, as analyzed by ANOVA followed by Tukey
post-hoc test
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experiments, the length of gestation and gender distribution
of the offspring were not altered upon aNK and eDC
treatments with respect to the control group (Figures 1b and c).
However, fetuses carried by aNK females appeared to be
smaller compared with eDC and control female mice on
E13.5 and E16.5 (Figures 1d and e). In addition, we noted
that pups delivered by aNK female mice showed a significant
decrease in body weight compared with control and eDC
mice on PN4 (Figure 1f), suggesting that aNK influences fetal
and post-natal body mass.
Decreased body weights in the progeny correlate with
structural changes and impaired placental function. As
uterine NK cells have been associated with the modulation of
placental physiology during early and mid-pregnancy,13,14
our next aim was to characterize structural changes in
placental development. It was previously described that
increased synthesis of placental alkaline phosphatase
(PLAP), which facilitates the transfer of nutrients across the
cell membrane to the developing fetus, corresponds to the
increased nutritional demand of the fetus during growth.15,16
While control and eDC placentas showed no overt differ-
ences, aNK mice displayed lower levels of PLAP activity
(Figure 2a). However, the proportional depth of the placental
disc (Pl) including the labyrinth (L) and junctional zone (Jz),
relative to the decidua, was similar between the analyzed
groups (Figures 2b and c). Further morphometric analysis
revealed that aNK placentas had a similar fractional area
occupied by the Jz compared with control and eDC mice. To
investigate differences in placental vascularity we focused on
the labyrinth zone, which consists of cells of trophectodermal
and mesodermal origin that together undergo branching
morphogenesis resulting in a large surface area for nutrient
and gas exchange between the mother and fetus. Interest-
ingly, upon analysis of the isolectin B4 (IB4) staining, a
marker that highlights the extracellular matrix surrounding
fetal blood vessels,17 eDC placentas exhibited a significant
decrease in the number of embryonic vascular branches
Figure 2 Manipulation of the relative NK cell–DC abundance during early pregnancy alters placental development and function. (a) NK cell depletion alters placental
function, as noted by decreased placental alkaline phosphatase (PLAP) activity on E10.5 with respect to control and eDC mice. (b) Histological analysis of Isolectin B4 (IB4)
stained uterine sections obtained during E10.5. DB, decidua basalis; Jz, junctional zone; MLAp, mesometrial lymphoid aggregate of pregnancy; PI, placenta. (c) Placental
depth related to the decidua (as noted by the PI:PIþDB ratio) and the fractional area occupied by the Jz were similar in all groups analyzed. (d) Left panel; density of maternal
vascular (IB4 ). Right panel: fetal vascular density of labyrinth, as noted by the presence of IB4þ vessels. (e) Representative examples of E10.5 uterine sections stained
with PAS. Arrows highlight glycogen vacuolated cells associated with the Jz. (f) Spiral artery remodeling, as analyzed on trichrome-stained sections on E10.5. Insets show that
spiral arteries in dNK mice remain undilated, as noted by artery width (mm). (g) Accumulation of mature NK cells (PASþDBAþ ) in the MLAp. Number of both tissue- (ta) and
vascular-associated (va) NK cells was significantly increased in dNK and eDC mice with respect to control females. In all figures, data shown are mean±S.E.M. derived from
six to eight mice per group and significant difference are noted as *Po0.0 and ***Po0.001 according to the Mann–Whitney U-test. Scale bars¼ 100 and 50mm
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when compared with control mice (Figure 2d, right panel). Of
note, the density of maternal branches did not show
differences between the analyzed groups (Figure 2d, left
panel). In addition, histological examination of the junctional
layer showed an increased number of periodic acid-schiff
(PAS)-positive vacuolated cells (glycogen cells) in eDC mice
(Figure 2e). Morphological changes of the maternal spiral
arteries (e.g., increased diameter and a concomitant loss of
mural smooth muscle cells) occur during mid gestation in
order to increase blood flow to the placental bed.6 Trichrome
staining showed that although control implantation sites had
dilated, represented by thin-walled arteries in the central,
proximal region of the decidua basalis at E10.5 (Figure 2f),
the vessels in this region of aNK placentas had narrower
lumens and a cuffed appearance, indicative of a thickened
arterial wall (Figure 2f). Analysis of the presence of PASþ
DBAþ granulated NK cells, which facilitate dilation of spiral
arteries,14 showed similar abundances and distribution
patterns (e.g., tissue-associated (ta) and vascular-asso-
ciated (va)) in the decidua basalis in all groups analyzed
(Figure 2g). In the mesometrial lymphoid aggregate of
pregnancy , however, aNK and eDC mice showed increased
numbers of both va and ta NK cells.
Epigenetic regulation within the developing and post-
natal liver is affected by in utero manipulation of NK
cell–DC relative abundance. To determine whether
changes in placental structure upon NK depletion and DC
expansion were associated with epigenetic dysregulation, we
first determined the global DNA methylation levels for fetal
liver, brain and kidney by LUminometric Methylation Assay
(LUMA) (Figures 3a–c). DNA methylation levels in the fetal
liver strongly depended on the gestational age, where an
average 10% increase in methylation levels was observed
on PN4 compared with E13.5. However, no significant
differences were observed between the control, aNK and
eDC groups in the fetal liver on E13.5. Interestingly, we
observed a significant change in the methylation levels in the
livers derived from aNK and eDC dams on PN4 (Figure 3a).
In addition, global methylation in both the fetal brain and
kidney did not significantly differ between fetuses carried by
control, aNK and eDC dams (Figures 3b and c). The global
methylation levels as determined by LUMA in these organs
appeared to be independent of the gestational age of the
fetal mice, as no differences were observed between E13.5
and PN4 (Figures 3b and c).
As a second approach to determine global methylation
levels, we developed a LINE-1 pyrosequencing assay. The
methylation of five individual CpG’s within the LINE-1
promoter was analyzed after bisulfite conversion and ampli-
fication by PCR (Supplementary Table 1). As shown in
Figure 3d, LINE-1 methylation in the liver was higher at PN4
compared with E13.5. In addition, on PN4 LINE-1 methylation
patterns were lower in the aNK- and eDC-derived pups
compared with the controls (Figure 3d, Supplementary
Figure 1). The brain and kidney LINE-1 methylation analysis
showed similar patterns between the experimental groups on
E13.5 and PN4 (Figures 3e and f).
In order to evaluate the effect of NK–DC treatments on
organ- and gene-specific changes in epigenetic regulation, we
next focused on the methylation levels of several candidate
gene promoters (Supplementary Table 2). As a first step, we
measured methylation of the insulin-like-growth-factor 2 (Igf2)
locus (Igf2/H19), a classical example of imprinting. DNA
methylation was similar between the experimental groups in
all organs or time points for both the Igf2 Differentially
Methylated Region 2 (Igf2-DMR2, Figure 4a) and the H19
Imprinting Control Region (H19 ICR, Figure 4b). However, the
Igf2-DMR2 in the fetal brain at E13.5 derived from fetuses
carried by aNK dams showed higher methylation levels
Figure 3 Global methylation levels as determined by LUMA and pyrosequencing of the LINE-1 promoter after bisulfite conversion. Data are shown for both embryonic day
13.5 (E13.5) and post-natal day 4 (PN4). (a) LUMA-Liver, (b) LUMA-Brain, (c) LUMA-Kidney, (d) LINE-Liver, (e) LINE-Brain and (f) LINE-Kidney. White bars show global
methylation within the control group, gray bars from the NK-depleted group and the black bars from the DC expanded group. Data represent mean±S.D.-derived from 10 to
15 embryos/pups per group. Significant differences are noted as *Po0.05 and **Po0.01 according to ANOVA followed by Tukey post-hoc test
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compared with control and eDC dams. In addition, we examined
nuclear receptors (e.g., promoters of the glucocorticoid receptor:
nuclear receptor subfamily 3, group C, member 1 (Nr3c1),
Ppara,Pgc1a andHnf4a). Overall, very low levels of methylation
were found within the CpG island-associated promoters of both
Nr3c1 and Ppara (Figures 4c and d).Nr3c1 showed subtle but
significantly higher methylation levels in the fetal brain on
E13.5 and in the liver on PN4 in offspring-derived from aNK
dams (Figure 4d), while methylation levels of the Ppara
promoter were not different for the three organs and two time
points analyzed (Figure 4c).
The Pgc1a promoter showed a remarkable pattern in the
fetal liver, where on E13.5 the aNK group displayed
significantly decreased methylation levels compared with
control and eDC groups. However, on PN4 the liver tissue
derived from aNK dams showed a significant increase in the
methylation levels in comparison to eDC group (Figure 4e).
Next, we analyzed the methylation levels of the Hnf4a
promoter, in which we found a significant upregulation in the
kidney of the aNK group on E13.5 and PN4 in comparison with
control and eDC mice (Figure 4f).
Finally, the relative mtDNA copy number was measured by
qPCR. In the brain, significant differences were detected on
E13.5 but disappeared with the overall increase in copy
number toward PN4 (Figure 5a). However, in liver and kidney
tissue we found that the overall mtDNA copy number was
increased between the post-natal groups (Figures 5b and c),
indicating differential regulation in different organs analyzed.
Discussion
The placenta is a transitory organ that is essential for the
development of healthy offspring. DC and NK cells within the
decidua influence processes such as tolerance to alloanti-
gens, angiogenesis and decidualization, which could have an
impact on placental development. In this study, we provide
clear evidence that alterations of NK cell and DC relative
abundance during early pregnancy modify the placentation
process and these modifications are associated with epi-
genetic changes in the offspring. Overall, aNK had a stronger
effect on placental dysfunction than DC expansion. Depleted
NK dams had narrower arterial lumens and diminished PLAP
activity, which could influence nutrient delivery and contribute
to the growth restriction observed in the offspring. Changes
observed in aNK females, mostly in the architecture of the
spiral artery walls within the decidua basalis, agree well with
Figure 5 Relative mtDNA content. (a) brain, (b) liver and (c) kidney. White bars show global methylation within the control group, gray bars from the NK-depleted group
and the black bars from the tissue-derived DC expanded group. Data are shown for both embryonic day 13.5 (E13.5) and post-natal day 4(PN4). Data represent mean±S.D.
derived from 10 to 15 embryos/pups per group. Significant differences are noted as *Po0.05 and **Po0.01 according to ANOVA followed by Tukey post-hoc test
Figure 4 Promoter-specific DNA methylation. (a) Igf2-DMR2, (b) H19 ICR, (c) Ppara, (d) Nr3c1, (e) Pgc1a and (f) Hnf4a P1 were analyzed in the brain, liver and kidney.
Data are shown for both embryonic day 13.5 (E13.5) and post-natal day 4 (PN4). White bars show promoter-specific DNA methylation within the control group, gray bars from
the NK-depleted group and the black bars from the brain, liver and kidney tissues derived from the DC expanded group. Data represent mean±S.D. derived from 10 to 15
embryos/pups per group. Significant differences are noted as *Po0.05 and **Po0.01 according to ANOVA followed by Tukey post-hoc test
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the classical role ascribed to NK cells in modulating placental
physiology during early and mid-pregnancy.13,14 However, a
striking observation from this study is that eDC placentas
displayed similar alterations. Like aNKmice, eDC females had
an increase in accumulation of mature NK cells in the MLAp;
indicating that similar mechanisms based on NK cell
reconstitution (i.e., increased recruitment and/or maturation
of precursors in the deciduas) are triggered in both groups to
sustain placental function. Importantly, the similarities regard-
ing arterial remodeling observed between eDC and aNK
females highlight the notion that DC-derived signals shape the
uterine milieu at the onset of implantation, establishing a
critical window that determines NK cell functions later in
gestation.
The fact that eDC placentas had a significant decrease in
fetal vascular branch density further suggests that fms-like
tyrosine kinase 3 ligand (FL) axis could be implicated in the
regulation of placental morphogenesis. This is an intriguing
hypothesis that awaits further investigation; especially con-
sidering previous reports on placental expression of the FL
receptor in the labyrinth region.18,19 In this context, the
labyrinth layer is the main site of contact between fetal and
maternal circulation, consisting of a highly branched fetal
vascular network in close apposition to trophoblast-lined
maternal sinusoids. Labyrinth formation involves complex
reciprocal interactions between trophoblasts and incipient
vessels.20 However, it is important to note that offspring-
derived from eDC did not suffer from IUGR, suggesting that
the changes in fetal branch density do not affect the nutritional
status upon FL treatment.
Abnormal placental function is often associated with IUGR,
a relatively common problem and a cause of significant
perinatal morbidity and mortality.9 Recently, IUGR has been
associated with epigenetic changes, due to diminished
nutrient supply and/or stress responses in the offspring.21
Epigenetic modifications mainly consist of DNA methylation
and histone modification, both of which are able to regulate
gene expression. Some of these changes are likely heritable,
that is, they are maintained through multiple cell divisions and
thereby contribute to the increased risk for chronic disease
(Developmental Origins of Health and Disease hypothesis). In
our study, we demonstrated that the placental dysfunction
seen in offspring derived from aNK dams was associated with
differential DNA methylation. Genome-wide methylation
levels were found to be significantly reduced in the PN4 liver
of offspring derived from aNK dams, most probably reflecting
an indirect contribution of maternal NK cells to epigenetic
programming of the offspring. Thus, NK cells would contribute
to shaping the intrauterine milieu by virtue of their role as
major regulators of maternal vascular development and
remodeling, a physiological process that will ensure adequate
nutrient and oxygen supply to the developing fetus. In
contrast, we observed no differences in general DNA
methylation in the brain and kidneys. The absence of
differential methylation in the brain may be explained by
counter regulatory mechanisms, which spare the brain tissue
from metabolic changes in the rest of the body.22 In addition,
the kidney seems to be more susceptible to maternal
undernutrition23 with high impact on kidney development
and nephron numbers, possibly involving gene-specific
epigenetic changes rather than global DNA methylation
levels.
The vast majority of mammalian DNAmethylation occurs at
CpG dinucleotides,24 concentrated in genomic regions called
CpG islands. Such regulatory regions are often unmethylated
within gene promoters of actively transcribed housekeeping
genes and tumor suppressor genes,25 whereas CpG islands
of silent genes are predominantly methylated.26 Our studies in
gene-specific DNA methylation demonstrated that offspring-
derived from aNK dams display an increasedmethylation. We
found high methylation of Igf2-DMR2 and glucocorticoid
receptor (Nr3c1) in the PN4 brain and altered methylation
patterns in Pgc1a in liver and Hnf4a in the kidney. Hnf4a is
expressed in the liver and kidney (proximal tubules) and
previous studies have shown epigenetic regulation of this
locus during fetal development.27,28 As methylation changes
were present on both E13.5 and PN4, our observations may
be related to long-term epigenetic adaptations. Interestingly,
the promoter region ofHnf4a near the transcription start site is
suggested to behave like an organ-specific differentially
methylated region (T-DMR) and found to be hypomethylated
in the liver,29 a finding which was supported by our data.
Similarly, the non-CpG island-associated promoter of the
Pgc1a showed distinct organ-specific methylation patterns,
where overall methylation levels were higher in the fetal liver
compared with brain and kidney. This also points toward
developmental regulation in the fetal liver between E13.5 and
PN4 that seems to be disturbed in the aNK-derived offspring.
Although we do not have an explanation for these organ-
specific effects, it is tempting to speculate that either some loci
are more vulnerable to environmental factors than others, or
that specifically regulated mechanisms, such as preferential
perfusion of the brain or reduced blood flow to the liver during
placental dysfunction act on the epigenome. The brain, which
is preferentially perfused as a fetal adaptive mechanism to
shortage of supplies during poor placental function, is thus
largely protected from detrimental effects of poor placental
function, whereas the liver, in this adaptive mechanism, is
underperfused.30 In addition, it is unclear to what extent the
observed organ- and developmental-specific effects on
methylation in our model may be related to underlying
differences in cell-type populations, as it has become
increasingly clear that different cell-type populations within a
tissue share a unique epigenetic signature.30
Finally, changes in mitochondrial DNA copy number
occurred between the control, aNK and eDC offspring. The
brain was affected early in fetuses derived from aNK and eDC
dams, but brain mitochondrial copy number increased during
development and reached the same level in all groups
analyzed. This might be indicative of an intrinsic regulation
of copy numbers in the brain, which is spared from the
detrimental effects of placental dysfunction. In the liver and
kidney, the differences occurred at PN4, which may be
related to the compensatory underperfusion of these
organs. Together, our findings indicate that the fetal
epigenome is indeed affected by maternal depletion of NK
cells, whereas the eDC mice are comparable with control
animals. Furthermore, genome-wide epigenetic profiling of
the fetal liver has suggested that its development extends to
several weeks postnatally and is accompanied by large
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changes in associated promoter methylation and gene
expression.31,32 Although it is well established that environ-
mental cues can also directly alter the epigenetic state of
genes, a large body of evidence suggests that (detrimental)
environmental cues during critical periods of organ develop-
ment can leave specific permanent epigenetic marks that
extend well into adulthood. Our data indicate that placental
dysfunction due to NK cell temporary ablation may indeed
disturb long-term epigenetic regulation at least in the liver and
kidney, while the brain is spared. Hence, future research needs
to address whether this leads to long-term metabolic changes.
Materials and Methods
Mice. Five- to six-week-old C57BL/6 CD11c.DTR female mice, which express
the diphtheria toxin receptor (DTR) under the control of the CD11c promoter
(described by Jung et al.33), were purchased from Jaxmice (Sacramento, CA,
USA) and maintained in our animal facility with a 12L/12D cycle. The presence of
a vaginal plug after cohabitation of CD11c.DTR females (H2b) with Balb/c males
(H2d) was denoted as day E0.5 of semiallogeneic pregnancy. Animal care and
experimental procedures were performed according to the state authority for
Animal Use in Research and Education. Expansion of DC or depletion of NK cells
was performed as previously described.2 Briefly, temporary depletion of NK cells
was achieved by injecting i.p. anti-asialo GM1 Ab (WAKO, Dusseldorf, Germany,
Cat. no. 986–10001, 2 mg/g BW) on E4.5. Control CD11c.DTR females received
i.p. injection of PBS supplemented with rabbit normal serum (2 mg/g BW). eDC
was performed by treating pregnant female mice on E0.5 with one daily i.p.
injection of human recombinant (FL: BioX cell, Cologne, Germany, Cat. no.
BE0098, 10mg/mouse/day) for 7 consecutive days. On E10.5, E13.5 and E16.5,
mice from the respective groups (n¼ 5-6) were narcotized, killed and uterine
tissue from the implantation sites were processed for histological analysis. In
addition, fetuses (E13.5 and E16.5) and pups (post-natal day 4, PN4) were
obtained from control, aNK and eDC female mice and fixed in Bouin’s solution and
subsequently cleared in 70% ethanol for body weight measurement and Theiler
stage analysis.34
Histological analysis. Paraffin-embedded uterine samples from E10.5 were
cut into 4-mm-thick sections and stained with hematoxylin-eosin (H&E), PAS and
Masson’s trichrome according to standard procedures. Samples were evaluated for
alkaline phosphatase activity using our standard protocol. Briefly, slides were
rehydrated and washed in TBS 0.05% Tween. For staining, slides were coated with a
Fast Red Violet–Naphthol AS-BI phosphate mixture and incubated in the dark for
10 min at room temperature. The slides were rinsed in TBS 0.05% Tween and
mounted with Kaiser’s aqueous mounting media. Negative controls were established
by incubating the slides in Dual Endogenous Enzyme Block (S2003, Dako, Hamburg,
Germany) for 30 min at room temperature prior to the staining step. Tissue sections
were examined using a light microscope (Axiophot, Zeiss, Oberkochen, Germany)
and photographs were taken with an Axio Cam HRc (Zeiss). Photo documentation
was performed using the digital image analysis system Spot advanced software,
version 8.6 (Visitron Systems GmbH, Puchheim, Germany).
Isolectin B4 staining. Staining of 8 mm sections was performed by washing
in TBS, followed by blocking of endogenous peroxidase through incubation with
3% hydrogenperoxide (H2O2) in methanol for 30 min at room temperature. After
incubation with 2% normal serum for 20 min, primary Ab against IB4 (1 : 200,
Sigma-Aldrich, Munich, Germany) was incubated over night at 4 1C. The slides
were then washed and incubated with HRP-conjugated secondary Abs (Jackson
ImmunoResearch, Suffolk, England) for 1 h at room temperature. The signal was
detected by incubating at room temperature with a 0.2 mg/ml diaminobenzidine
(Dako Cytomation, Hamburg, Germany) in 0.05% H2O2 substrate solution. After
washing, nuclei were counterstained with 0.1% Mayer’s hematoxylin followed
by a standard dehydration procedure and mounting in Vitro-Clud medium
(R Langenbrinck, Baden-Wu¨rttemberg, Germany). Negative controls with irrelevant
IgG showed no specific immunoreactivity.
DBA lectin/PAS dual staining. After deparaffinization and rehydratation,
the paraffin-embedded sections were stained using the protocol previously
described.35
Fetal development analysis. Embryos/fetuses were fixed with Bouin’s
solution for 2–24 h, then washed with 70% ethanol several times (daily, until Bouin
was cleared) and stored in 70% ethanol at room temperature. Body weight was
recorded after fixation. Developmental stages were determined as previously
described (http://www.emouseatlas.org/emap/home.html).
DNA isolation. Fetal tissues (brain, kidneys and liver) were homogenized
using a Tissue Lyser LT (Qiagen, Hilden, Germany) in standard lysis buffer
containing RNAse A and Proteinase K. The samples were subsequently extracted
two times with 25 : 24 : 1 chloroform/phenol/isoamylalcohol, pH 8.0 (Ultrapure,
Fluka, BioChemika, Buchs, Switzerland), precipitated with isopropanol and
washed using 70% ethanol. All samples were characterized on a Nanodrop2000c
(ThermoScientific, Pittsburgh, PA, USA) for purity and concentration of the
genomic DNA. Integrity and purity were confirmed on a 0.8% agarose gel.
LUMA. LUMA was used to measure global levels of DNA methylation by
restriction digestion using the methylation sensitive HpaII/MspI isoschizomers and
quantification of the resulting overhangs by pyrosequencing.36,37 Individual
samples were digested with both HpaIIþ EcoRI and MspIþEcoRI, (Fermentas)
as separate reactions, where the EcoRI functions as an internal control. In total,
500 ng of genomic DNA was used for the individual restrictions, incubated for 4 h
at 37 1C. Lambda DNA and in vitro CpG methyltransferase (M.SssI; New England
Biolabs) treated Lambda DNA were used as controls. Samples were run on a
Pyromark Q24 platform (Qiagen, KJ Venlo, The Netherlands) in duplicate. Peak
heights were normalized to EcoRI to calculate global methylation levels as
previously described.36,37
Pyrosequencing of gene-specific promoters and LINE-1. As a
second approach for the determination of global methylation levels, we developed
a pyrosequencing assay targeting the mouse LINE-1 repetitive element promoter.
The LINE-1 promoter consists of four repeats, is present as thousands of
individual copies on both the human and mouse genomes and may function as a
representative of the entire genome.38–40 In brief, the blastn algorithm (with low
complexity filtering off) was used to retrieve a list of LINE-1 promoter elements
located in the mouse genome and a ClustalX alignment was made.41 Bisulfite-
specific primers were developed using the Pyromark Assay design 2.0 software
(Qiagen). The primers amplify a reasonably conserved region of the mouse LINE-1
promoter containing five CpGs in total (see Supplementary Table 1 for a detailed
description including sequences and schemes). To identify common single-
nucleotide polymorphisms that could interfere with the pyrosequencing assay
itself, the PCR products were cloned and sequenced (Baseclear, Leiden, The
Netherlands). From these sequence data, an A/T SNP was identified that could
lead to out-of-frame sequencing; this was added as a non-CpG SNP to the
sequence to analyze (AQ-mode). Genomic DNA (200 ng) was bisulfite-converted
using the EZ DNA methylation gold kit, (Zymo Research, Leiden, The
Netherlands) according to the manufacturer’s protocol. LINE-1 was amplified by
HotStar Mastermix (Qiagen) (see Supplementary Table 1 for the PCR conditions).
The PCR product was purified using streptavidin Sepharose HP beads and
hybridization of the sequencing primer with the biotinylated PCR product was
performed as described in the PyroMark Q24 vacuum workstation guide (Qiagen).
Gene-specific assays were amplified using a universal primer design as described
previously.42 Finally, the Pyromark Q24 software (Qiagen) was used to determine
the methylation percentage of the individual CpG positions analyzed. Primer
sequences and standard curves for assay validation are shown in Supplementary
Figure 2.
Statistical analysis. The number of animals included in each experimental
group was indicated accordingly. Data are presented as mean±S.D. from two or
three replicate experiments. Statistical significance was determined using ANOVA
followed by Tukey’s test, with a P-value of less than 0.05 being considered as
significant.
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